BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1799355)

  • 1. Premenstrual syndrome and spironolactone.
    Burnet RB; Radden HS; Easterbrook EG; McKinnon RA
    Aust N Z J Obstet Gynaecol; 1991 Nov; 31(4):366-8. PubMed ID: 1799355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, placebo-controlled evaluation of spironolactone in the premenstrual syndrome.
    Vellacott ID; Shroff NE; Pearce MY; Stratford ME; Akbar FA
    Curr Med Res Opin; 1987; 10(7):450-6. PubMed ID: 3621990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study.
    Wang M; Hammarbäck S; Lindhe BA; Bäckström T
    Acta Obstet Gynecol Scand; 1995 Nov; 74(10):803-8. PubMed ID: 8533564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of premenstrual syndrome by spironolactone.
    O'Brien PM; Craven D; Selby C; Symonds EM
    Br J Obstet Gynaecol; 1979 Feb; 86(2):142-7. PubMed ID: 371663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group.
    Thys-Jacobs S; Starkey P; Bernstein D; Tian J
    Am J Obstet Gynecol; 1998 Aug; 179(2):444-52. PubMed ID: 9731851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the efficacy of progesterone pessaries in the relief of symptoms of premenstrual syndrome. progesterone Study Group.
    Magill PJ
    Br J Gen Pract; 1995 Nov; 45(400):589-93. PubMed ID: 8554838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bromocriptine on the premenstrual syndrome. A double-blind clinical trial.
    Andersen AN; Larsen JF; Steenstrup OR; Svendstrup B; Nielsen J
    Br J Obstet Gynaecol; 1977 May; 84(5):370-4. PubMed ID: 329858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine and clinical effects of spironolactone in female hyperandrogenism.
    Siegberg R; Ylöstalo P; Laatikainen T; Pelkonen R; Stenman UH
    Arch Gynecol; 1987; 240(2):67-73. PubMed ID: 3566358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine and premenstrual tension: a clinical and hormonal study.
    Andersch B; Hahn L
    Pharmatherapeutica; 1982; 3(2):107-13. PubMed ID: 7201645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial.
    Schmidt K; Weber N; Steiner M; Meyer N; Dubberke A; Rutenberg D; Hellhammer J
    Clin Nutr ESPEN; 2018 Apr; 24():22-30. PubMed ID: 29576358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premenstrual tension: a placebo-controlled efficacy study with spironolactone and medroxyprogesterone acetate.
    Hellberg D; Claesson B; Nilsson S
    Int J Gynaecol Obstet; 1991 Mar; 34(3):243-8. PubMed ID: 1673942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a nutritional supplement on premenstrual symptomatology in women with premenstrual syndrome: a double-blind longitudinal study.
    London RS; Bradley L; Chiamori NY
    J Am Coll Nutr; 1991 Oct; 10(5):494-9. PubMed ID: 1955626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.
    Yonkers KA; Pearlstein T; Fayyad R; Gillespie JA
    J Affect Disord; 2005 Apr; 85(3):317-21. PubMed ID: 15780701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of curcumin on serum brain-derived neurotrophic factor levels in women with premenstrual syndrome: A randomized, double-blind, placebo-controlled trial.
    Fanaei H; Khayat S; Kasaeian A; Javadimehr M
    Neuropeptides; 2016 Apr; 56():25-31. PubMed ID: 26608718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential fatty acids for premenstrual syndrome and their effect on prolactin and total cholesterol levels: a randomized, double blind, placebo-controlled study.
    Rocha Filho EA; Lima JC; Pinho Neto JS; Montarroyos U
    Reprod Health; 2011 Jan; 8():2. PubMed ID: 21241460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive.
    Graham CA; Sherwin BB
    J Psychosom Res; 1992 Apr; 36(3):257-66. PubMed ID: 1564678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial.
    Schmidt PJ; Grover GN; Rubinow DR
    Arch Gen Psychiatry; 1993 Jun; 50(6):467-73. PubMed ID: 8498881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome.
    Freeman EW; Rickels K; Sondheimer SJ; Polansky M
    JAMA; 1995 Jul; 274(1):51-7. PubMed ID: 7791258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial.
    Doll H; Brown S; Thurston A; Vessey M
    J R Coll Gen Pract; 1989 Sep; 39(326):364-8. PubMed ID: 2558186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome.
    Freeman E; Rickels K; Sondheimer SJ; Polansky M
    JAMA; 1990 Jul; 264(3):349-53. PubMed ID: 2194047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.